Ativan
NDC Package 65084-463-10
Package Information
Ativan is a medication used to treat serious seizures that do not stop (status epilepticus). Marketed by Mckesson Corporation Dba Rx Pak, this product is identified by NDC 65084-463 and is authorized under FDA application NDA017794.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 65084 - Mckesson Corporation Dba Rx Pak
- 65084-463 - Ativan
- 65084-463-10 - 100 TABLET in 1 BOTTLE
- 65084-463 - Ativan
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65084-463-10 identifies a specific commercial package of 100 tablet in 1 bottle of Ativan, labeled by Mckesson Corporation Dba Rx Pak. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mckesson Corporation Dba Rx Pak on May 01, 2013. The current certification is valid through September 01, 2019.
What are the primary indications for this medication?
This medication is used to treat serious seizures that do not stop (status epilepticus). It is also used before surgeries or procedures to cause drowsiness, decrease anxiety, and cause forgetfulness about the procedure or surgery. Lorazepam belongs to a class of medications called benzodiazepines, which produce a calming effect on the brain and nerves (central nervous system). It is thought to work by increasing the effect of a certain natural chemical (GABA) in the brain.
How is this Mckesson Corporation Dba Rx Pak product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65084046310. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.